Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients: a cluster randomised controlled trial

Barts and The London Queen Mary's School of Medicine and Dentistry (UK)0 个研究点目标入组 136 人开始时间: 2009年4月6日最近更新: 2016年10月17日

适应症

试验速览

暂无简介。

•The only inclusion criterion for teams is that they are a dedicated assertive outreach team (AOT) and operate a corresponding policy. The only exclusion criteria are lack of willingness to participate and an already existing practice of money for medication (MfM).
•For patients in the AOTs there are the following inclusion criteria:
•1. Being cared in the AOT for at least 4 months
•2. Aged between 18 and 65 years of age, either sex
•3. Capacity to give informed consent to participate in the study and actual written informed consent
•4. An established diagnosis of schizophrenia, schizo-affective psychosis, or bipolar illness according to the International Classification of Diseases, 10th Edition (ICD-10)
•5. Being prescribed depot injections of anti-psychotic medication
•6. Poor adherence to anti-psychotic medication, i.e., missed 50% or more of prescribed depot injections, over the last 4 months (so that the percentage of taken depots is based on a minimum of 4 prescribed depots)
•7. Failure of all other methods available to the team to ensure adherence to medication

•1. Learning difficulty
•2. Poor command of English so that clinical communication and discussion of agreements is impaired

发起方

Barts and The London Queen Mary's School of Medicine and Dentistry (UK)